Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
Hanno H. Leuchte, MD*,*,
Michael Holzapfel*,
Rainer A. Baumgartner*,
Isabelle Ding, MD*,
Claus Neurohr, MD*,
Michael Vogeser, MD ,
Tilman Kolbe, MD*,
Martin Schwaiblmair, MD* and
Jürgen Behr, MD*
* Division of Pulmonary Diseases, Department of Internal Medicine I, Munich, Germany
Department of Clinical Chemistry, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany

View larger version (21K):
[in a new window]
|
Figure 1 (A to D) Correlation of resting hemodynamic parameters with brain natriuretic peptide (BNP) levels in primary pulmonary hypertension (PPH). (A) Pulmonary vascular resistance (PVR) vs. BNP; r = 0.61; p = 0.001; (B) mean pulmonary artery pressure (PAP) vs. BNP; r = 0.49; p = 0.01; (C) right atrial pressure (RAP) vs. BNP; r = 0.78; p < 0.001; (D) cardiac index (CI) vs. BNP; r = 0.48; p < 0.05.
|
|

View larger version (9K):
[in a new window]
|
Figure 2 (A to C) Correlation of exercise parameters with brain natriuretic peptide (BNP) levels in primary pulmonary hypertension. (A) BNP vs. 6-min walk; r = 0.7; p < 0.001; (B) BNP vs. peak oxygen uptake (peak VO2); r = 0.61; p < 0.01; (C) BNP vs. World Health Organization (WHO) functional class, r = 0.79; p < 0.001. WHO class II vs. class III; p < 0.001.
|
|

View larger version (10K):
[in a new window]
|
Figure 3 (A, B) Correlation of World Health Organization (WHO) functional class with peak oxygen uptake (peak VO2) and 6-min walk (6 MW) in primary pulmonary hypertension. (A) Correlation of WHO functional class with peak VO2; r = 0.73; p < 0.001; (B) correlation of WHO functional class with 6 MW; r = 0.86; p < 0.001.
|
|
|